Anavex Life Sciences Corp. AVXL
$ 8.59
1.42%
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиКвартальный отчет 2024-Q2
добавлен 06.08.2024
Anavex Life Sciences Corp. Мультипликаторы 2011-2024 | AVXL
Мультипликаторы по годам Anavex Life Sciences Corp.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.8 | -19.1 | -24.1 | -13.3 | -5.2 | -6.1 | -12.6 | -7.1 | -16.2 | -0.6 | -4.5 | -3.4 | -6.5 |
P/S |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-0.6 | -0.6 | -0.5 | - | -0.5 | -0.4 | -0.3 | -0.4 | -0.7 | -0.3 | -0.1 | - | - |
EV (Enterprise Value) |
375 млн | 776 млн | 772 млн | 327 млн | 119 млн | 87.7 млн | 146 млн | 98.1 млн | 184 млн | 6.69 млн | 19.1 млн | 31.3 млн | 49 млн |
EBITDA per Share |
-0.7 | -0.66 | -0.6 | -0.53 | -0.591 | -0.428 | -0.381 | -0.423 | -0.382 | -0.299 | -0.267 | -0.613 | -0.982 |
EV/EBITDA |
- | -12.0 | -3.9 | -4.4 | -9.2 | -6.4 | -25.5 | -1.8 | -7.7 | -6.7 | -7.9 | ||
PEG |
-0.95 | -1.51 | -2.78 | -1.63 | 0.13 | 0.34 | -0.59 | -0.2 | -0.37 | 0.0 | -0.08 | 0.92 | -0.22 |
P/B |
3.6 | 6.4 | 6.1 | 12.8 | 6.7 | 5.2 | 7.0 | 16.5 | 15.4 | 35.3 | -6.7 | -9.9 | -41.9 |
P/CF |
-18.5 | -37.7 | -30.0 | -16.4 | -7.3 | -8.5 | -18.8 | -11.3 | -46.5 | -2.6 | -21.3 | -16.8 | -12.6 |
ROE % |
-33.49 | -33.67 | -25.14 | -96.49 | -129.60 | -85.17 | -55.50 | -233.61 | -94.53 | -5901.77 | 150.21 | 288.74 | 639.63 |
ROA % |
-30.77 | -31.42 | -23.46 | -76.08 | -103.81 | -71.60 | -48.35 | -155.14 | -78.27 | -154.60 | -940.41 | -63116.44 | -3598.89 |
ROCE % |
-39.31 | -35.78 | -27.85 | -114.14 | -141.98 | -93.62 | -64.07 | -235.83 | -55.50 | -50.22 | 136.80 | 150.10 | 541.02 |
Current Ratio |
12.3 | 15.0 | 15.0 | 4.7 | 5.0 | 6.3 | 7.8 | 3.0 | 5.8 | 5.1 | 0.2 | 0.0 | 0.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Anavex Life Sciences Corp.
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.14 | -0.13 | -0.11 | - | -0.14 | -0.17 | -0.17 | - | - | - | -0.14 | - | -0.14 | -0.12 | -0.12 | -0.35 | -0.11 | -0.12 | -0.12 | -0.43 | -0.13 | -0.12 | -0.15 | -0.26 | -0.06 | -0.16 | -0.09 | -0.12 | -0.04 | -0.04 | -0.08 | -0.24 | -0.06 | -0.06 | -0.12 | -0.44 | -0.22 | -0.12 | -0.06 | -0.04 | -0.03 | -0.02 | 0.01 | -0.02 | -0.01 | 0.01 | 0.01 | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | - | - | - | - | -0.2 | - | -0.16 | -0.15 | -0.15 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -0.08 | -0.03 | -0.06 | -0.06 | -0.03 | -0.02 | -0.01 | -0.02 | - | -0.01 | -0.01 | -0.12 | -0.02 | -0.01 | -0.08 | -0.19 | -0.06 | -0.08 |
ROE % |
-31.27 | -29.55 | -30.76 | -26.32 | -49.96 | -50.48 | -48.30 | -46.14 | -39.86 | -38.14 | -42.04 | -51.57 | -108.79 | -116.32 | -122.53 | -130.96 | -158.33 | -169.45 | -177.87 | -188.03 | -138.31 | -129.73 | -146.92 | -127.26 | -107.11 | -105.45 | -78.75 | -79.27 | -177.58 | -198.21 | -232.20 | -250.21 | -172.52 | -170.11 | -151.10 | -282.97 | -1096.87 | -1587.62 | -1965.17 | -1820.36 | -924.86 | -250.79 | 143.07 | 178.16 | 438.01 | 576.54 | 606.87 | 680.89 | 1031.78 | 1382.67 | 1557.26 | 639.63 | 639.63 | 190.36 |
ROA % |
-28.90 | -27.42 | -28.35 | -24.12 | -46.19 | -46.76 | -45.03 | -43.23 | -37.37 | -35.77 | -34.30 | -41.83 | -84.43 | -97.09 | -114.79 | -121.31 | -144.17 | -151.14 | -154.43 | -164.77 | -127.58 | -113.52 | -117.58 | -100.59 | -85.93 | -87.21 | -71.71 | -72.11 | -128.87 | -139.49 | -158.03 | -171.51 | -128.56 | -132.38 | -124.82 | -107.78 | -86.83 | -73.14 | -58.28 | 190.56 | 32.42 | -894.27 | -792.42 | -1597.71 | -64533.30 | -126709.33 | -130248.49 | -132251.61 | -72734.07 | -13216.52 | -10839.56 | -3598.89 | -3598.89 | -1071.05 |
ROCE % |
-38.18 | -36.05 | -36.55 | -30.38 | -38.65 | -37.69 | -35.48 | -23.84 | -23.84 | -15.58 | -8.01 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -11.81 | -23.62 | -30.32 | -181.40 | -1390.80 | -1897.52 | -2420.95 | -2239.52 | -1002.97 | -479.32 | 63.38 | 57.34 | 158.13 | 177.29 | 179.19 | 254.90 | 560.59 | 679.62 | 856.74 | 433.65 | 143.31 | 191.58 |
Current Ratio |
12.0 | 15.1 | 11.8 | 12.3 | 14.3 | 11.3 | 11.2 | 14.9 | - | - | - | 15.0 | 17.9 | - | - | 4.7 | - | - | - | 5.0 | - | - | - | - | - | - | - | 7.8 | - | - | - | 3.0 | 4.4 | 3.9 | 5.5 | 5.8 | 5.8 | 5.8 | 1.1 | 1.0 | 1.0 | 1.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | - | - | - | 0.0 | 0.1 | 0.1 | 0.1 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD